First Cited
Last Cited

Articles citing This Document (Page 1 of 3)

Chapter 9 Nanomaterials and Nanotechnologies for Photon Radiation Enhanced Cancer TreatmentNATO Science for Peace and Security Series B: Physics and Biophysics2018
Arzneiverordnungen 2014 im Überblick2015
Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal StudyJournal of Medical Internet Research2016
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance DatabaseDrugs - Real World Outcomes2021
Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World DataInternational Journal of Environmental Research and Public Health2021
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approvalBritish Journal of Clinical Pharmacology2020
A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USATherapeutic Innovation and Regulatory Science2019
Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in OncologyDrug Safety2019
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in OncologyDrug Safety2019
Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysisPLoS ONE2019
Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report : Radiation/systemic drug combo in metastatic melanomaCancer Chemotherapy and Pharmacology2019
Global Disparities: Can the World Afford Cancer?2019
Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative ChlorobutanolDrug Safety2019
HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introductionHIV Medicine2019
Complexity of Biologics CMC Regulation2019
Research and development of mAb drugs in China: a look from policy perspectivesHuman Vaccines and Immunotherapeutics2019
Readability assessment of package leaflets of biosimilarsBMJ Open2019
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare deliveryPLoS ONE2019
Copies of nonbiological complex drugs: generic, hybrid or biosimilar?Drug Discovery Today2019
Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS)BioDrugs2018
Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Infection of Human MacrophagesFrontiers in Immunology2018
Parenteral protein formulations: An overview of approved products within the European UnionEuropean Journal of Pharmaceutics and Biopharmaceutics2018
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and TrustOncologist2018
Appendix 3—Marketed Biotherapeutics2018
Selected Biotherapeutics Overview2018
Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the ImplicationsFrontiers in Pharmacology2018
[Predictive value of PD-L1 diagnostics]Der Pathologe2018
"Market withdrawals" of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendationsHealth Economics Review2018
Drug Interactions With New Synthetic OpioidsFrontiers in Pharmacology2018
EU Perspective on BiosimilarsAAPS Advances in the Pharmaceutical Sciences Series2018
Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal diseaseGastroenterología Y Hepatología2018
Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulantsOncotarget2018
Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal diseaseGastroenterología Y Hepatología (English Edition)2018
Recommendations for the design of small population clinical trialsOrphanet Journal of Rare Diseases2018
Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in GermanyValue in Health2018
Sample Size for Multiple Hypothesis Testing in Biosimilar DevelopmentStatistics in Biopharmaceutical Research2018
Portrait of women with type 1 or type 2 diabetes of childbearing age attending diabetes clinics in Italy: the AMD-Annals initiativeActa Diabetologica2018
Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological EvaluationJournal of Pharmaceutical Sciences2018
Conflicting meal recommendations for oral oncology drugs: pose risks to patient care?European Journal of Clinical Pharmacology2018
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanismsPharmacology & Therapeutics2018
Anticoagulant prophylaxis and therapy in children: current challenges and emerging issuesJournal of Thrombosis and Haemostasis2018
Immunogenicity Assessment of BiosimilarsPharmaceutical Medicine2018
An F-Labeled Poly(ADP-ribose) Polymerase Positron Emission Tomography Imaging AgentJournal of Medicinal Chemistry2018
Extension Study of PF-05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid ArthritisArthritis Care and Research2018